메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국유방암학회 Journal of Breast Disease Journal of Breast Disease 제7권 제2호
발행연도
2019.1
수록면
81 - 88 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: Breast cancer rates are expected to rise with an increasingly aging society. However, research on breast cancer among elderly women is scarce. In the present study, we aimed to investigate the clinicopathological features of elderly women with breast cancer and assess their clinical outcomes following adjuvant chemotherapy. Methods: Patients who underwent curative surgery for breast cancer between January 1, 2009 and December 31, 2014 were retrospectively reviewed (n=1,865). The clinicopathological features, comorbidities, and survival outcomes were compared among three age groups (<55, 55–64, and ≥65 years). Subgroup analyses were also performed according to adjuvant chemotherapy status (i.e., administered or forgone) and need. Results: The median age of the patients (n=1,865) was 51.7 years, and 231 (12.3%) patients were ≥65 years of age (defined as elderly). The median follow-up period was 56 months. The tumor characteristics were similar among the three age groups, except for tumor size and progesterone receptor status. The five-year overall survival rate was significantly poorer in elderly patients (87.5%) than in the younger groups (<55 years: 94.1%; 55–64 years: 93.2%) (p=0.002). Elderly patients received significantly less frequent adjuvant chemotherapy than the younger patients (p<0.001). Not all elderly patients in need of adjuvant chemotherapy were administered chemotherapy. Those administered adjuvant chemotherapy had significantly higher five-year overall survival rates than that of the non-administered patients (86.5% vs. 66.5%, p=0.014) and marginally longer breast cancer-specific survival (87.9% vs. 73.5%, p=0.07). Elderly patients who did not undergo chemotherapy had a higher prevalence of diabetes mellitus than those who did. Conclusion: Adjuvant chemotherapy in elderly breast cancer patients improved overall survival, and marginally extended breast cancer-specific survival. Therefore, standard adjuvant chemotherapy should be considered in elderly patients who require it.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0